AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Saphnelo (anifrolumab) — Worldwide YoY actual by Quarter
Saphnelo (anifrolumab) — Worldwide YoY actual (%) (%)
AstraZeneca Saphnelo (anifrolumab) — Worldwide YoY actual: 25.0% in Q2 2026, down 24.0 pts from a year earlier. That is the lowest of the 11 quarters on record here.
Where the Q2 2026 figure comes from
“|| Saphnelo | | 209 | | 25 | | 24 | | 175 | | 21 | | 7 | | 68 | | 64 | | 19 | | 58 | | 51 | | 8 | | 31 | | 38”
Source: Form 6-K FY2026Q2 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Saphnelo (anifrolumab) — Worldwide YoY actual (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 25.0% | -24.0 pts | Form 6-K FY2026Q2 Earnings Release ↗ |
| Q1 2026 | Mar 31, 2026 | 25.0% | -24.0 pts | Form 6-K FY2026Q1 Earnings Release ↗ |
| Q4 2025 | Dec 31, 2025 | 38.0% | -27.0 pts | Form 6-K FY2025Q4 Earnings Release ↗ |
| Q3 2025 | Sep 30, 2025 | 45.0% | -18.0 pts | Form 6-K FY2025Q3 Earnings Release ↗ |
| Q2 2025 | Jun 30, 2025 | 49.0% | -16.0 pts | Form 6-K FY2025Q2 Earnings Release ↗ |
| Q1 2025 | Mar 31, 2025 | 49.0% | -45.0 pts | Form 6-K FY2025Q1 Earnings Release ↗ |
| Q4 2024 | Dec 31, 2024 | 65.0% | -21.0 pts | Form 6-K FY2024Q4 Earnings Release ↗ |
| Q3 2024 | Sep 30, 2024 | 63.0% | – | Form 6-K FY2024Q3 Earnings Release ↗ |
| Q2 2024 | Jun 30, 2024 | 65.0% | – | Form 6-K FY2024Q2 Earnings Release ↗ |
| Q1 2024 | Mar 31, 2024 | 94.0% | – | Form 6-K FY2024Q1 Earnings Release ↗ |
| Q4 2023 | Dec 31, 2023 | 86.0% | – | Form 6-K FY2023Q4 Earnings Release ↗ |
Cite this data
StockData. (2026). AstraZeneca Saphnelo (anifrolumab) — Worldwide YoY actual (%), quarterly Q4 2023–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-saphnelo-world-act-yoy
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.